DioGenix Issued Seminal Patent for Diagnosing Early-stage Neurological Diseases
3/18/2013 10:13:59 AM
More...
|
DioGenix Raises $1.5 Million in Series B Financing for Novel Molecular Diagnostic for Multiple Sclerosis, MSPrecise
12/18/2012 8:57:25 AM
More...
|
DioGenix' MSPrecise Identifies Early-Stage Patients With Multiple Sclerosis
11/9/2012 9:35:50 AM
More...
|
DioGenix' MSPrecise Identifies Early-Stage Patients with Multiple Sclerosis
11/8/2012 10:51:23 AM
More...
|
DioGenix and Fast Forward, LLC Collaborate to Develop Blood-Based Molecular Diagnostic for Multiple Sclerosis
11/8/2012 10:48:08 AM
More...
|
DioGenix Spins Off from Parent Company
9/23/2008 6:35:16 AM
More...
|